Press Release IMFINZI® (durvalumab) regimen reduced the risk of disease recurrence or death by 32% in high-risk non-muscle-invasive bladder cancer in the POTOMAC Phase III trial 17 October 2025
Press Release Butterfly Network to Report Third Quarter 2025 Financial Results on October 31, 2025 17 October 2025
Press Release Samsung Electronics Completes Acquisition of Xealth, Accelerating Connected Care 17 October 2025
Press Release ClearNote Health to Showcase Latest Advancements in Early Cancer Detection Testing at ESMO Congress 2025 17 October 2025
Press Release KBRA Releases Research – The Forward Look—European and UK Credit Views: Q4 2025 17 October 2025
Press Release State Street Corporation (NYSE: STT) Reports Third-Quarter 2025 Financial Results 17 October 2025
Press Release 2 Day Virtual Pre-Filled Syringes Training Course: Gain a Practical Overview of the Complete Processing Journey from Component Selection to Quality Control (ONLINE EVENT: Nov 5th – Nov 6th, 2025) – ResearchAndMarkets.com 17 October 2025
